FDU-PB-22

FDU-PB-22 is a designer drug that belongs to the cannabinoid class. It is an ingredient found in synthetic cannabis products. It is a potent agonist for the CB1 receptor and CB2 receptor.

Chemistry

FDU-PB-22, also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-5-(4-fluorophenyl)-4-methylpyrazole-3-carboxamide, is a derivative of PB-22 where the 8-hydroxyquinoline has been replaced by a 4-fluorobenzyl group.

Pharmacology

FDU-PB-22 acts as a full agonist with a binding affinity of 1.19nM at CB1 and 1.04nM at CB2 cannabinoid receptors. It has been linked to hospitalizations and deaths due to its potent nature.

Legality

FDU-PB-22 is a controlled substance in some countries due to its psychoactive properties. In the United States, it is a Schedule I controlled substance. It is also illegal in the European Union.

See also

• JWH-018
• AM-2201
• 5F-PB-22
• PB-22
• QUPIC
• SDB-005
• NM-2201
• 5F-NNE1
• 5F-CUMYL-PINACA

FDU-PB-22 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski